SCHEMBL4734

SCHEMBL4734

Cc1noc(-c2ccc(-c3ccc(C4(CC(=O)O)CC4)cc3)cc2)c1N(Cc1ccccc1)C1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.37
ABCC4 O15439 1/20 0.37
ABCB11 O95342 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
ABCB4 P21439 1/20 0.37
LPAR1 Q92633 1/20 0.37
ABCC2 Q92887 1/20 0.37
SLCO1B3 Q9NPD5 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.36
SLC6A2 P23975 10/20 0.36
SLC6A4 P31645 9/20 0.36
SLC6A3 Q01959 8/20 0.36
SLC6A9 P48067 1/20 0.34
BRD4 O60885 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4182 0.91 BRD4 (0.38) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL3539 0.89 ABCC3 (0.47) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL4809 0.85 OPRM1 (0.48) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6633 0.74 LPAR1 (0.37) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6531 0.74 LPAR1 (0.37) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7297 0.72 SCD5 (0.35) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6150 0.72 BRD4 (0.36) BRD4ALDH1A1
SCHEMBL6082 0.72 HDAC1 (0.34) CYP2C9ALDH1A1MAPTCYP2D6
SCHEMBL7534 0.72 L3MBTL1 (0.34) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL4790 0.71 BRD4 (0.34) ABCC3ABCC4ABCB11CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed